dBET1 is a CRBN-based BET degrader-based PROTAC compound consisting of the BET bromodomain antagonist (+)-JQ1 linked to a cereblon E3 ubiquitin ligase ligand. Of the 7,429 proteins, only the oncoproteins MYC and PIM1, as well as BRD2, BRD3, and BRD4, were significantly downregulated by dBET1 treatment.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
